PolNet

PolNet enables quantitative analysis of endothelial cell polarity and hemodynamics across entire in vivo vascular networks to study blood flow–driven vascular morphogenesis.


Key Features:

  • Image acquisition, segmentation, and analysis protocol: Provides a protocol for acquiring images, segmenting vascular structures, and quantifying endothelial cell polarity across extensive vascular networks.
  • Computational Fluid Dynamics (CFD): Integrates computational fluid dynamics to characterize hemodynamics within reconstructed vascular networks.
  • Network-level analysis: Performs network-level analyses that link flow metrics to individual endothelial cell polarity and position within the vascular mesh.
  • Correlation with cellular and molecular observations: Enables correlation of blood flow dynamics with cellular and molecular experimental observations.

Scientific Applications:

  • Endothelial cell polarization and migration: Quantifies endothelial cell polarity and migration patterns in relation to local hemodynamic conditions.
  • Vascular patterning and development: Investigates mechanisms underlying vascular development by combining polarity measurements with flow characterization.
  • Normal and pathological vessel formation: Explores interactions between cellular polarity and hemodynamic forces to provide insight into normal and pathological morphogenesis.

Methodology:

Image acquisition, segmentation and image analysis combined with computational fluid dynamics (CFD) modeling of flow within reconstructed vascular networks.

Topics

Details

License:
LGPL-3.0
Tool Type:
desktop application
Operating Systems:
Linux, Windows, Mac
Added:
8/4/2018
Last Updated:
11/25/2024

Operations

Publications

Bernabeu MO, Jones ML, Nash RW, Pezzarossa A, Coveney PV, Gerhardt H, Franco CA. PolNet: A Tool to Quantify Network-Level Cell Polarity and Blood Flow in Vascular Remodeling. Biophysical Journal. 2018;114(9):2052-2058. doi:10.1016/j.bpj.2018.03.032. PMID:29742399. PMCID:PMC5961748.

PMID: 29742399
PMCID: PMC5961748
Funding: - Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção: EXPL-BEX-BCM-2258-2013, IF/00412/2012, LISBOA-01-0145-FEDER-007391, PRECISE-LISBOA-01-0145-FEDER-016394 - European Research Council: 311719 - British Council: 679368, 692322 - Engineering and Physical Sciences Research Council: EP/L00030X/1 - Cancer Research UK: FC001999 - Fondation Leducq: 17 CVD 03, MR/L016311/1

Documentation